# Compass Therapeutics, Inc. — Form D

Compass Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-07-01. The offering totals $70.0M, of which $60.5M was reported sold. Industry: Other.

## Offering

- Filed: 2020-07-01
- Form: D
- Accession: 0001802806-20-000004
- Industry: Other
- Exemptions: 06b
- Total offering: $70.0M
- Amount sold: $60.5M
- Remaining: $9.5M
- Investors: 110
- Date of first sale: 2020-06-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-370115

## Issuer

- Name: Compass Therapeutics, Inc.
- CIK: 0001738021
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 245 FIRST STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-500-8099

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| PHILIP J FERNEAU | Director | CAMBRIDGE, MA |
| Carl L Gordon | Director | Stamford, CT |
| THOMAS J SCHUETZ | Director | CAMBRIDGE, MA |
| Stephen P Squinto | Director | New York, NY |
| Julie Sunderland | Director | CAMBRIDGE, MA |
| Vered P Bisker-Leib | Executive Officer | Cambridge, MA |
| THOMAS J SCHUETZ | Executive Officer | CAMBRIDGE, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-07-01](https://search.stillhousedata.com/formd/0001802806-20-000003) | D | $195.3M | $195.3M |

## More

- [CIK 1738021 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1738021&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001802806-20-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.